PROBLEM OF METABOLIC DISORDERS IN CHILDREN WITH JUVENILE ARTHRITIS LIVING IN THE REPUBLIC OF MORDOVIA
https://doi.org/10.14412/1995-4484-2014-572-577
Abstract
It is assumed that juvenile idiopathic arthritis (JIA), as many other rheumatic diseases, is in close pathogenic connection with metabolic disorders and early atherosclerosis. However, the prevalence of metabolic syndrome and its components both in healthy Finno-Ugrian children and teens and JIA patients is unknown.
Objective of the present work was to study the prevalence of metabolic disorders in children with JIA, living in the Republic of Mordovia.
Subjects and methods. Authors have examined 82 children (among them 44 girls) with JIA aged 10–18 years. Results. Full complex of metabolic syndrome symptoms was revealed in 36.6% of patients, most of which had arthritis. Dyslipidaemia, obesity and arterial hypertension were recorded most frequently and correlated with activity of the disease and the dose of systemic glucocorticoids.
Conclusion. JIA is associated with high prevalence of metabolic disorders which only partially (arterial hypertension and carbohydrate metabolism disorders) are connected with glucocorticoid therapy and mainly determined by the high inflammatory activity of the disease.
About the Authors
A. V. Krasnopolskaya
N.P. Ogaryov Mordovia State University,
Saransk, Russia
Russian Federation
Russian Federation
L. A. Balykova
N.P. Ogaryov Mordovia State University,
Saransk, Russia
Russian Federation
Russian Federation
T. I. Kornilova
N.P. Ogaryov Mordovia State University,
Saransk, Russia
Russian Federation
Russian Federation
A. A. Shirokova
N.P. Ogaryov Mordovia State University,
Saransk, Russia
Russian Federation
Russian Federation
References
1. Клиппел ДжЛ, Стоун ДжХ, Кроффорд ПДж, Уайт ПХ. Ревматические заболевания. Том 2. аболевания костей и суставов. Под ред. Е.Л. Насонова, В.А. Насоновой, Ю.А. Олюнина. Москва: ГЭОТАР-Медиа; 2012. 520 с. [Klippel JL, Stoun JH, Krofford PJ, Uait PH. Revmaticheskie zabolevaniya. Tom 2. Zabolevaniya kostei i sustavov [Rheumatic diseases. Vol. 2. Diseases of bones and joints]. Nasonov EL, Nasonova VA, Olyunin YuA, editors. Moscow: GEOTAR-Media; 2012. 520 p.]
2. Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther. 2008;10(2):R30. DOI: 10.1186/ar2383. Epub 2008 Mar 6.
3. Solomon DH, Karlso EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107(9):1303–7. DOI: http://dx.doi.org/10.1161/01.CIR.0000054612.26458.B2.
4. Kitas GD, Gabriel ShE. Cardiovascular disease in rheumatoid arthritis state of the art and future perspectives. Ann Rheum Dis. 2011;70(1):8–14. DOI: 10.1136/ard.2010.142133. Epub 2010 Nov 24.
5. Mok CC, Ko GT, Ho LY, et al. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken). 2011 Feb;63(2):195–202. DOI: http://dx.doi.org/10.1002/acr.20363.
6. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28(2):385–90. DOI: http://dx.doi.org/10.2337/diacare.28.2.385.
7. Ferreira AP, Oliveira CE, Franca NM. Metabolic syndrome and risk factors for cardiovascular disease in obese children: the relationship with insulin resistance (HOMA-IR). J Pediatr. 2007;83(1):21–6. DOI: http://dx.doi.org/10.2223/JPED.1562.
8. Gremese E, Ferraccioli G. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev. 2011 Aug;10(10):582–9. DOI: http://dx.doi.org/10.1016/j.autrev.2011.04.018.
9. Crowson CS, Myasoedova E, Davis JM 3rd, et al. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol. 2011 Jan;38(1):29–35. DOI: http://dx.doi.org/10.3899/jrheum.100346.
10. Kavey RE, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation. 2006;114(24):2710–38. DOI: http://dx.doi.org/10.1161/CIRCULATIONAHA. 106.179568.
11. Zimmet P, Alberti KG, Kaufman F, et al.; IDF Consensus Group. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes. 2007;8(5):299–306. DOI: http://dx.doi.org/10.1111/j.1399-5448.2007.00271.x.
12. Pietrewicz E, Urban M. Early atherosclerosis changes in children with juvenile idiopathic arthritis. Pol Merkur Lekarski. 2007;22(129):211–4.
13. Goncalves Marangoni R, Hayata AL, Borba EF, et al. Decreased high-density lipoprotein cholesterol levels in polyarticular juvenile idiopathic arthritis. Clinics. 2011;66(9):1549–52. DOI: http://dx.doi.org/10.1590/S1807-59322011000900007.
14. Glowinska-Olszewska B, Bossowski A, Dobrenko E, et al. Subclinical cardiovascular system changes in obese patients with juvenile idiopathic arthritis. Mediators Inflamm. 2013;2013:436702. DOI: 10.1155/2013/436702. Epub 2013 Mar 11.
15. Zanette CA, Machado SH, Tavares Brenol JC, Xavier RM. Metabolic syndrome and juvenile idiopathic arthritis. Rev Bras Reumatol. 2010;50(2):190–204. DOI: http://dx.doi.org/10.1590/S0482-50042010000200008.
16. Despres JP, Lemieux I, Bergeron J, et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol. 2008;28(6):1039–49. DOI: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20.
17. Toms TE, Kitas GD. Dyslipidemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors. Curr Vasc Pharmacol. 2010;8(3):301–26. DOI: http://dx.doi.org/10.2174/157016110791112269.
18. Ostchega Y, Carroll M, Prineas RJ, et al. Trends of elevated blood pressure among children and adolescents: data from the National Health and Nutrition Examination Survey1988–2006. Am J Hypertens. 2009;22(1):59–67. DOI: http://dx.doi.org/10.1038/ajh.2008.312.
19. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(11):2276–83. DOI: http://dx.doi.org/10.1161/ATVBAHA. 107.147835.
20. Hollan I, Meroni PL, Ahearn JM, et al. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013 Aug;12(10):1004–15. DOI: http://dx.doi.org/10.1016/j.autrev.2013.03.013.
Review
For citations:
Krasnopolskaya A.V., Balykova L.A., Kornilova T.I., Shirokova A.A. PROBLEM OF METABOLIC DISORDERS IN CHILDREN WITH JUVENILE ARTHRITIS LIVING IN THE REPUBLIC OF MORDOVIA. Rheumatology Science and Practice. 2014;52(5):572-577. (In Russ.) https://doi.org/10.14412/1995-4484-2014-572-577
Views:
1039
Email this article 